Enteral Nutrition Support for Adult Patients with Fat Malabsorption

Enteral Nutrition Support for Adult Patients with Fat Malabsorption

Issue link: https://eguideline.guidelinecentral.com/i/1289696

Contents of this Issue

Navigation

Page 13 of 15

14 Pancreatic Enzyme Delivery with Enteral Nutrition Table 10. Pancreatic Enzyme Delivery for EN – Advantages and Limitations Product Advantages Limitations Lipase cartridge • FDA approved for EN use • Research shows efficacy with EN • Maintains closed EN systems • Ease of use • Does not contribute to total daily lipase limit • Continuously hydrolyzes fat in the formula during EN infusion • Requires pump for EN infusion • Cannot use with oral diet • Cannot use with bolus or gravity feeding • Cannot use formulas with insoluble fiber as they clog the cartridge • Availability dependent on individual hospital or outpatient pharmacy • Requires new cartridge for every 500 mL of formula needed • Formulas vary in % fat hydrolysis https://www.relizorb.com/docs/pdfs/ Compatible-Formulas-and-Pumps.pdf Oral/enteral pancreatic enzymes • Can be used for bolus feedings • Does not require a pump • Can be given orally or with EN • Broad availability in hospital or outpatient pharmacies • Only one product FDA-approved for EN use • Lacks research showing efficacy with EN despite historical use • Counts toward total daily lipase units • Crushing enzymes is labor intensive • Using crushed enzymes increases the chance of clogging a feeding tube • If given orally, must be given frequently since enzyme activity is time-limited • Enzymes and EN may not mix effectively if not delivered together

Articles in this issue

Links on this page

view archives of Enteral Nutrition Support for Adult Patients with Fat Malabsorption - Enteral Nutrition Support for Adult Patients with Fat Malabsorption